Open access
Open access
Powered by Google Translator Translator

Cardiomyopathies

Cohort Study | Younger age at hypertrophic cardiomyopathy diagnosis, male sex among predictors of developing LV systolic dysfunction

11 Aug, 2023 | 15:16h | UTC

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry – Circulation

 

Commentary on Twitter

 


Phase 1 Trial | NI006 shows potential for cardiac amyloid depletion in transthyretin amyloid cardiomyopathy

1 Aug, 2023 | 14:17h | UTC

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial – TCTMD

Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid – American College of cardiology

 


AHA Scientific Statement | Treatment strategies for cardiomyopathy in children

12 Jun, 2023 | 13:49h | UTC

Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association – Circulation

News Releases:

Identifying the cause of heart muscle disease in children is key to effective treatment – American Heart Association

Children with heart muscle disease need more personalized treatment plans – American Heart Association

Top Things to Know: Treatment Strategies for Cardiomyopathy in Children – American Heart Association

 


Review | Takotsubo syndrome: more frequent in women, more dangerous in men

12 May, 2023 | 13:21h | UTC

Takotsubo syndrome: more frequent in women, more dangerous in men – European Heart Journal Supplements

See all articles in the series here


Guideline | Diagnosis and treatment of myocarditis

23 Mar, 2023 | 12:55h | UTC

JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis – Circulation Journal (see PDF)

Related: Brazilian Society of Cardiology Guideline on Myocarditis – 2022 – Arquivos Brasileiros de Cardiologia

 


Review | Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

20 Mar, 2023 | 13:21h | UTC

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis – European Heart Journal

Related: Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis – Journal of the American Heart Association

 


Review | Pathophysiological gaps, diagnostic challenges, and uncertainties in cardiac sarcoidosis

17 Mar, 2023 | 12:47h | UTC

Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis – Journal of the American Heart Association

 


Phase 2 RCT | Aficamten in patients with obstructive hypertrophic cardiomyopathy

14 Feb, 2023 | 10:37h | UTC

Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy – Journal of the American College of Cardiology

 


Review | Valvular heart disease: shifting the focus to the myocardium

7 Feb, 2023 | 13:37h | UTC

Valvular heart disease: shifting the focus to the myocardium – European Heart Journal

 

Commentary on Twitter

 


2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis

24 Jan, 2023 | 14:29h | UTC

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Key Points: 2023 ACC Expert Consensus on Cardiac Amyloidosis – American College of Cardiology

News Release: ACC Expert Consensus Decision Pathway Focuses on Diagnosis and Management of Cardiac Amyloidosis – American College of Cardiology

 

Commentary on Twitter

 


The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies

9 Jan, 2023 | 14:10h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies – European Heart Journal

 

Commentary on Twitter

 


Cohort Study | Prognostic prediction of genotype vs. phenotype in genetic cardiomyopathies.

23 Nov, 2022 | 13:57h | UTC

Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies – Journal of the American College of Cardiology

 

Commentary on Twitter

 

Under a Creative Commons license

 


Review | Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.

4 Nov, 2022 | 13:28h | UTC

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy – Heart

 


Consensus Paper | Diagnosis and management of syncope in hypertrophic cardiomyopathy.

31 Oct, 2022 | 13:49h | UTC

Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management – International Journal of Cardiology

 


Cohort Study | Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.

24 Oct, 2022 | 14:08h | UTC

Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy – European Heart Journal

Editorial: Arrhythmogenic cardiomyopathies in children: seek and you shall find – European Heart Journal

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ License

 


Review | Restrictive cardiomyopathy: definition and diagnosis.

24 Oct, 2022 | 13:58h | UTC

Restrictive cardiomyopathy: definition and diagnosis – European Heart Journal

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ License

 


Review | Cardiac care of children with Duchenne muscular dystrophy (DMD) and females carrying DMD-gene variations.

20 Oct, 2022 | 12:21h | UTC

Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations – openheart

 


Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the US.

13 Oct, 2022 | 13:51h | UTC

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States – Annals of Internal Medicine

News Release: Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children, younger adults in the US – American College of Physicians

 

Commentary on Twitter (thread – click for more)

 

Commentary on Twitter

 


Guideline | Evaluation and management of myocarditis.

12 Oct, 2022 | 13:56h | UTC

Brazilian Society of Cardiology Guideline on Myocarditis – 2022 – Arquivos Brasileiros de Cardiologia

 


Cohort Study | Cardiovascular MRI phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis.

30 Sep, 2022 | 12:39h | UTC

Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Cardiovascular magnetic resonance imaging phenotype with pathology-frequent late gadolinium enhancement associated with high-risk of ventricular arrhythmic and heart failure events – Physician’s Weekly

 

Commentary on Twitter

 


Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy.

26 Sep, 2022 | 11:57h | UTC

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy – Journal of the American College of Cardiology

Editorial: Genetic Testing for Dilated Cardiomyopathy: Old School Is New School – Journal of the American College of Cardiology

News Release: Scientists develop a tool to determine if dilated cardiomyopathy has a genetic origin  – Centro Nacional de Investigaciones Cardiovasculares Carlos III

 

Commentary on Twitter

 


Retrospective Cohort Study | Natural history of MYH7-related dilated cardiomyopathy.

14 Sep, 2022 | 13:06h | UTC

Natural History of MYH7-related Dilated Cardiomyopathy – Journal of the American College of Cardiology

 


20-year follow-up of a RCT trial | Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy.

26 Jul, 2022 | 13:33h | UTC

Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial – European Heart Journal

Commentary: Immunosuppression may benefit long term in virus-negative inflammatory cardiomyopathy – Healio (free registration required)

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by/4.0/ license

 


RCT | Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy.

13 Jul, 2022 | 11:52h | UTC

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy – Journal of the American College of Cardiology

Related: #ACC22 [Not published yet] – RCT: Mavacamten reduces the need for surgical intervention in patients with obstructive hypertrophic cardiomyopathy.

 


RCT | First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation.

11 Jul, 2022 | 12:21h | UTC

First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial – Circulation

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.